Menu
Menu
STDs & Women’s Health
COMMITTED TO CARE
Molecular Vaginal Panel (MVP)
What the test is for:
The Molecular Vaginal Panel (MVP) test is a diagnostic tool that analyzes vaginal samples for DNA or RNA of pathogens, aiding in the detection of infections like bacterial vaginosis and candidiasis. This precise screening enables prompt identification and targeted treatment, contributing to optimal reproductive health management in women.
Virus details:
The Molecular Vaginal Panel (MVP) test delves into the molecular details of viral infections in the female genital tract. This advanced diagnostic tool identifies specific viruses, enabling precise treatment strategies for improved reproductive health outcomes. The test’s molecular analysis ensures a thorough understanding of the viral landscape, facilitating tailored interventions.
What it detects:
Beyond viruses, the MVP delves into the microbial intricacies of vaginal health. It detects and assesses imbalances related to Bacterial Vaginosis (BV), the presence of Trichomonas vaginalis, and Candida (Yeast) infections. By providing a holistic view of bacterial and parasitic influences, the MVP aids in tailoring personalized treatment plans and promoting optimal reproductive well-being.
Book Your Test Online
Streamline your health journey with quick and convenient lab test scheduling. Book your tests effortlessly online for a seamless experience.
STDs Women's Health
Respiratory
Frequently Asked Questions
Z Diagnostics MVP is an automated qualitative in vitro diagnostic test for the detection of DNA targets from anaerobic bacteria associated with bacterial vaginosis (BV), Candida species associated with vulvovaginal candidiasis (VVC), and Trichomonas vaginalis (TV).
Z Diagnostics MVP test uses clinician-collected and self-collected vaginal swabs (collected in a clinical setting) from patients who are symptomatic for vaginitis/vaginosis.
Z Diagnostics MVP test utilizes real-time polymerase chain reaction (PCR) for the amplification of specific DNA targets and utilizes fluorogenic target-specific hybridization probes to detect and differentiate DNA from anaerobic organisms associated with bacterial vaginosis (BV), Candida species associated with vulvovaginal candidiasis (VVC) and Trichomonas vaginalis (TV). A proprietary algorithm is used to determine BV status, based on the presence or absence of three anaerobic bacteria associated with BV - Atopobium spp. (Atopobium vaginae, Atopobium novel species CCUG 55226), Bacterial Vaginosis-Associated Bacterium 2 (BVAB2) and Megasphaera-1.
The Z Diagnostics MVP test is intended to aid in the diagnosis of vaginal infections in women with a clinical presentation consistent with BV, VVC, or TV.
Yes, it is common. According to the literature, 17.9% of women with vaginal discharge symptoms have mixed infections, with the most common mixed infections being BV and VVC (11.2%).
Yes, both Z Diagnostics MVP and Z Diagnostics CT/NG use SWAB/G-50-US.